Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
Michael Nowak, Mohammed S. Arredouani, Adrian Tun-Kyi et al. · 2010
Read Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide by Michael Nowak, Mohammed S. Arredouani, Adrian Tun-Kyi et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011311.txt.
Description
Nowak, Arredouani, Tun-Kyi and colleagues rescued immune cells in prostate tumors for PLOS ONE in 2010. A class of immune sentinels, NKT cells, should attack tumors but were poorly activated by prostate tumor cells. The team tested a pairing of an immune signal and a fat based activator to fix that fault.
The pairing corrected the defective activation in their experiments. Recruiting NKT cells back into the fight is a goal of cancer immunotherapy. A defined rescue recipe can be tested for wider use. It shows tumor immune faults may be reversible, not fixed, which widens treatment options.
Catalog record
| CREATOR | Michael Nowak, Mohammed S. Arredouani, Adrian Tun-Kyi et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011311